Angelalign Technology (HKSE:06699) Cash-to-Debt : 52.69 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Angelalign Technology's cash to debt ratio for the quarter that ended in Dec. 2023 was 52.69.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Angelalign Technology could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Angelalign Technology's Cash-to-Debt or its related term are showing as below:

HKSE:06699' s Cash-to-Debt Range Over the Past 10 Years
Min: 12.83 Med: 57.32 Max: 129.39
Current: 52.69

During the past 6 years, Angelalign Technology's highest Cash to Debt Ratio was 129.39. The lowest was 12.83. And the median was 57.32.

HKSE:06699's Cash-to-Debt is ranked better than
84.52% of 840 companies
in the Medical Devices & Instruments industry
Industry Median: 1.97 vs HKSE:06699: 52.69

Angelalign Technology Cash-to-Debt Historical Data

The historical data trend for Angelalign Technology's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Angelalign Technology Cash-to-Debt Chart

Angelalign Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

22.07

61.94

119.75

129.39

52.69

Angelalign Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial					119.75	149.31	129.39	81.99	52.69

Competitive Comparison of Angelalign Technology's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Angelalign Technology's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angelalign Technology's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's Cash-to-Debt falls into.

Angelalign Technology Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Angelalign Technology's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3762.19	/	(31.349	+	40.05)
	=	52.69

Angelalign Technology's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3762.19	/	(31.349	+	40.05)
	=	52.69

Angelalign Technology (HKSE:06699) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Angelalign Technology Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology (HKSE:06699) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

AGLFF:USA

Address

No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN

Website

https://www.angelalign.com

Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Carecapital Ea, Inc	2201 Interest of corporation controlled by you
Carecapital Management Group Llc	2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited	2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited	2201 Interest of corporation controlled by you
Feng Dai	2201 Interest of corporation controlled by you
Shore Lead Limited	2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited	2101 Beneficial owner
Li Huamin	2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited	2101 Beneficial owner
Chen Kai	2201 Interest of corporation controlled by you
Jovial Day Global Limited	2201 Interest of corporation controlled by you
Vast Luck Global Limited	2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si	2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines